4//SEC Filing
Domzalski David 4
Accession 0001415889-25-001923
CIK 0001566044other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:15 PM ET
Size
5.9 KB
Accession
0001415889-25-001923
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (right to buy)
2025-01-21+730,000→ 730,000 totalExercise: $2.77Exp: 2035-01-20→ Common Stock (730,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727794
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:15 PM ET
- Size
- 5.9 KB